BioCentury
ARTICLE | Clinical News

Matrix Pharma preclinical data

April 18, 1994 7:00 AM UTC

MATX (Menlo Park, Calif.) presented animal data on a new, non-protein delivery system designed for cancer drugs that are not easily dissolved in water, and on its IntraDose system in pancreatic cancer.

Using the ADV system, a proprietary drug carrier whose exact composition will not be disclosed until a patent issues, MATX showed significantly improved efficacy for the poorly soluble drugs taxol and etoposide in a mouse model of tumor growth. ...